MOA-728
Sponsors
Bausch Health Americas, Inc.
Conditions
AdultConstipationHealthyIleusMetahdone-maintenance SubjectsMethadone-maintenance SubjectsPostoperative Complications
Phase 1
Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects
CompletedNCT00311350
Start: 2006-03-31End: 2006-08-31Target: 48Updated: 2019-11-25
Bioequivalence Study in Healthy Volunteers
CompletedNCT00387985
Start: 2006-08-31End: 2006-09-30Updated: 2019-11-25
Dose Ranging Study in Healthy Methadone Maintenance Subjects
CompletedNCT00387491
Start: 2006-06-30End: 2006-10-31Target: 16Updated: 2019-11-25
Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone
CompletedNCT00398502
Start: 2006-10-31End: 2006-12-31Updated: 2019-11-25
Study Evaluating MOA-728 Administered in Healthy Men
WithdrawnNCT00427258
Start: 2010-01-31Updated: 2019-11-29
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
CompletedNCT00434395
Start: 2007-03-31End: 2007-10-31Updated: 2019-11-25
Double-Blind, Double-Dummy, 2-Period Crossover of a 20-Minute Versus a 4-hour IV of MOA-728 in Stable Methadone Subjects
CompletedNCT00444158
Start: 2007-03-31End: 2007-07-31Target: 24Updated: 2019-11-25
Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance
CompletedNCT00447811
Start: 2007-03-31End: 2007-05-31Updated: 2019-11-25
Study Evaluating the Safety and Tolerability of a New Intravenous Formulation of MOA-728 in Healthy Subjects
CompletedNCT00464802
Start: 2007-04-30End: 2007-06-30Target: 36Updated: 2019-11-25
Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy
WithdrawnNCT00505583
Start: 2007-07-31End: 2007-12-31Updated: 2019-11-29
Phase 2
Study Evaluating Oral MOA-728 for the Treatment of Opioid-Induced Bowel Dysfunction (OIBD) in Subjects With Chronic Non-Malignant Pain
CompletedNCT00366431
Start: 2006-08-31End: 2007-03-31Target: 420Updated: 2019-11-25
Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
CompletedNCT00605644
Start: 2008-01-31End: 2008-05-31Updated: 2020-08-20